OncoSil Medical Limited has appointed Ms. Shelley Steyn as Chief Financial Officer, effective May 5, 2025, as part of its strategy to strengthen leadership during a critical development phase. Ms. Steyn’s extensive experience in financial roles is expected to enhance OncoSil’s strategic priorities, improve financial control, and support the company’s efforts in closing clinical trial recruitments and resubmitting a marketing authorization application to the Therapeutics Goods Association.
More treatments , expansion , approvals to come . CFO has worked with Sirtex which was taken over for around $1.9 billion. Stock price at all time lows. To say this is bizarre is a understatement.
understatement.
OncoSil Medical Limited has appointed Ms. Shelley Steyn as Chief...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |